12:00 AM
Nov 22, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Acetadote acetylcysteine regulatory update

Cumberland disclosed in its 3Q10 earnings that FDA accepted for filing and granted Priority Review to an sNDA from Cumberland for a next generation Acetadote...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >